Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the Company's own shares executed on September 24, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 246,227 ordinary shares
- Purpose: Cancellation under the Buyback Programme
- Highest Price Paid: 393.70 pence per share
- Lowest Price Paid: 389.00 pence per share
- Volume Weighted Average Price: 391.3646 pence per share
- Post-Transaction Share Capital: 9,114,905,197 ordinary shares
Material Changes
The primary material change reported is the reduction in the Company's registered share capital following the cancellation of 246,227 shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific corporate action. The Company notes that a full breakdown of individual trades is available via the London Stock Exchange and its investor website.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the current total registered share capital of 9,114,905,197 ordinary shares.
- Review the full trade breakdown at the provided RNS link for detailed execution data.
- Check if the share count reduction impacts any shareholder notification thresholds under the FCA's Disclosure Guidance and Transparency Rules.